| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli | 45 | 2025 | 984 | 5.000 |
Why?
|
| Stress, Physiological | 9 | 2018 | 256 | 2.230 |
Why?
|
| Mutagenesis | 18 | 2023 | 345 | 2.040 |
Why?
|
| DNA Repair | 24 | 2019 | 591 | 2.000 |
Why?
|
| Escherichia coli Proteins | 18 | 2023 | 304 | 1.790 |
Why?
|
| DNA Damage | 14 | 2025 | 516 | 1.530 |
Why?
|
| Recombination, Genetic | 20 | 2019 | 448 | 1.490 |
Why?
|
| DNA Replication | 12 | 2025 | 357 | 1.210 |
Why?
|
| Models, Genetic | 17 | 2019 | 761 | 1.100 |
Why?
|
| Genomic Instability | 8 | 2024 | 230 | 1.070 |
Why?
|
| Gene Amplification | 7 | 2012 | 236 | 1.050 |
Why?
|
| DNA Breaks, Double-Stranded | 14 | 2025 | 134 | 1.020 |
Why?
|
| Mutation | 27 | 2025 | 5903 | 0.990 |
Why?
|
| Lac Operon | 11 | 2011 | 96 | 0.970 |
Why?
|
| DNA Copy Number Variations | 8 | 2022 | 963 | 0.970 |
Why?
|
| Chromosomes, Bacterial | 6 | 2015 | 64 | 0.950 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2025 | 280 | 0.730 |
Why?
|
| Adaptation, Physiological | 5 | 2004 | 270 | 0.690 |
Why?
|
| Evolution, Molecular | 11 | 2012 | 669 | 0.670 |
Why?
|
| Point Mutation | 7 | 2013 | 351 | 0.670 |
Why?
|
| Adaptation, Biological | 5 | 2007 | 32 | 0.650 |
Why?
|
| Sigma Factor | 5 | 2019 | 35 | 0.630 |
Why?
|
| Gene Dosage | 4 | 2011 | 445 | 0.630 |
Why?
|
| Bacterial Proteins | 10 | 2019 | 887 | 0.620 |
Why?
|
| DNA-Directed DNA Polymerase | 4 | 2019 | 82 | 0.560 |
Why?
|
| Gene Rearrangement | 7 | 2019 | 323 | 0.550 |
Why?
|
| Nucleic Acid Heteroduplexes | 2 | 2013 | 17 | 0.540 |
Why?
|
| Biological Evolution | 3 | 2011 | 227 | 0.540 |
Why?
|
| RNA | 2 | 2023 | 574 | 0.490 |
Why?
|
| DNA Polymerase beta | 3 | 2010 | 14 | 0.480 |
Why?
|
| Perciformes | 2 | 2011 | 6 | 0.460 |
Why?
|
| Saccharomyces cerevisiae | 7 | 2025 | 429 | 0.460 |
Why?
|
| Gene Expression Regulation, Bacterial | 7 | 2023 | 157 | 0.460 |
Why?
|
| DNA Breaks, Single-Stranded | 2 | 2016 | 20 | 0.440 |
Why?
|
| DNA Polymerase II | 2 | 2010 | 20 | 0.430 |
Why?
|
| DNA, Bacterial | 9 | 2016 | 475 | 0.420 |
Why?
|
| DNA | 9 | 2023 | 1619 | 0.420 |
Why?
|
| Chromosomes, Fungal | 2 | 2012 | 49 | 0.420 |
Why?
|
| Selection, Genetic | 4 | 2012 | 154 | 0.420 |
Why?
|
| Chromosomal Instability | 2 | 2019 | 57 | 0.400 |
Why?
|
| DNA Replication Timing | 1 | 2011 | 11 | 0.380 |
Why?
|
| Chromosome Aberrations | 2 | 2011 | 620 | 0.380 |
Why?
|
| Clonal Evolution | 1 | 2011 | 41 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 5 | 2023 | 2429 | 0.370 |
Why?
|
| DNA-Binding Proteins | 7 | 2022 | 2061 | 0.370 |
Why?
|
| Mutagenesis, Insertional | 3 | 2025 | 150 | 0.360 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 560 | 0.340 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 264 | 0.320 |
Why?
|
| Sequence Homology | 1 | 2009 | 63 | 0.310 |
Why?
|
| Reactive Oxygen Species | 4 | 2022 | 495 | 0.300 |
Why?
|
| Chromatin | 1 | 2011 | 579 | 0.290 |
Why?
|
| DNA, Mitochondrial | 2 | 2024 | 211 | 0.290 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 664 | 0.290 |
Why?
|
| Oxidative Stress | 4 | 2007 | 818 | 0.280 |
Why?
|
| Neoplasms | 5 | 2021 | 2800 | 0.270 |
Why?
|
| Crossing Over, Genetic | 3 | 2011 | 50 | 0.240 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 3897 | 0.240 |
Why?
|
| Genetic Variation | 2 | 2013 | 1505 | 0.240 |
Why?
|
| Transcription, Genetic | 3 | 2025 | 1705 | 0.240 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2019 | 365 | 0.240 |
Why?
|
| DNA End-Joining Repair | 4 | 2025 | 37 | 0.240 |
Why?
|
| Replication Protein A | 1 | 2025 | 11 | 0.240 |
Why?
|
| Transcription Termination, Genetic | 1 | 2025 | 14 | 0.240 |
Why?
|
| Retroelements | 1 | 2024 | 41 | 0.230 |
Why?
|
| Heat-Shock Response | 1 | 2004 | 33 | 0.230 |
Why?
|
| Base Sequence | 9 | 2015 | 3109 | 0.220 |
Why?
|
| Drug Resistance | 1 | 2004 | 256 | 0.220 |
Why?
|
| Drug Resistance, Microbial | 4 | 2023 | 194 | 0.210 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 227 | 0.200 |
Why?
|
| DNA, Cruciform | 3 | 2021 | 18 | 0.200 |
Why?
|
| Exodeoxyribonucleases | 5 | 2025 | 51 | 0.190 |
Why?
|
| Genome | 1 | 2004 | 481 | 0.190 |
Why?
|
| Chromosome Fragility | 1 | 2021 | 13 | 0.190 |
Why?
|
| Viral Proteins | 2 | 2013 | 347 | 0.180 |
Why?
|
| Bacteriophage mu | 2 | 2018 | 12 | 0.180 |
Why?
|
| Thymine | 2 | 2011 | 15 | 0.180 |
Why?
|
| Frameshift Mutation | 4 | 2013 | 181 | 0.170 |
Why?
|
| Chromosomes | 1 | 2000 | 207 | 0.170 |
Why?
|
| Comparative Genomic Hybridization | 4 | 2022 | 573 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2019 | 372 | 0.160 |
Why?
|
| DNA, Single-Stranded | 2 | 2025 | 74 | 0.160 |
Why?
|
| DNA Polymerase III | 3 | 2025 | 28 | 0.150 |
Why?
|
| Rec A Recombinases | 3 | 2010 | 26 | 0.150 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2018 | 37 | 0.150 |
Why?
|
| DNA, Fungal | 2 | 1996 | 77 | 0.150 |
Why?
|
| DNA Polymerase I | 2 | 2010 | 10 | 0.150 |
Why?
|
| Signal Transduction | 1 | 2010 | 4595 | 0.140 |
Why?
|
| RecQ Helicases | 2 | 2016 | 62 | 0.140 |
Why?
|
| Phenotype | 6 | 2015 | 4269 | 0.140 |
Why?
|
| Deoxyguanine Nucleotides | 1 | 2017 | 5 | 0.140 |
Why?
|
| Genome, Human | 3 | 2019 | 1293 | 0.140 |
Why?
|
| Genomics | 3 | 2015 | 1520 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 262 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 5 | 2019 | 1763 | 0.140 |
Why?
|
| Genome, Bacterial | 2 | 2015 | 183 | 0.130 |
Why?
|
| Animals | 11 | 2023 | 34309 | 0.130 |
Why?
|
| Cell Division | 4 | 2019 | 780 | 0.130 |
Why?
|
| Humans | 23 | 2025 | 125438 | 0.120 |
Why?
|
| DNA Helicases | 3 | 2013 | 236 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 253 | 0.120 |
Why?
|
| Gene Library | 1 | 2015 | 218 | 0.120 |
Why?
|
| Alleles | 5 | 2012 | 1617 | 0.120 |
Why?
|
| Loss of Heterozygosity | 1 | 2015 | 130 | 0.120 |
Why?
|
| Models, Biological | 4 | 2010 | 1466 | 0.110 |
Why?
|
| Uniparental Disomy | 1 | 2015 | 49 | 0.110 |
Why?
|
| Homologous Recombination | 2 | 2012 | 93 | 0.110 |
Why?
|
| Genes, Bacterial | 2 | 2006 | 210 | 0.110 |
Why?
|
| Oxygen | 1 | 2018 | 556 | 0.110 |
Why?
|
| Cell Nucleus | 2 | 2024 | 680 | 0.110 |
Why?
|
| Likelihood Functions | 2 | 2011 | 114 | 0.110 |
Why?
|
| Exodeoxyribonuclease V | 3 | 2003 | 23 | 0.110 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 2025 | 121 | 0.110 |
Why?
|
| DNA Breaks | 1 | 2013 | 26 | 0.110 |
Why?
|
| Transcription Factors | 4 | 2022 | 2603 | 0.110 |
Why?
|
| Protein Engineering | 1 | 2013 | 72 | 0.110 |
Why?
|
| Serine Endopeptidases | 3 | 2010 | 181 | 0.100 |
Why?
|
| Bayes Theorem | 2 | 2011 | 286 | 0.100 |
Why?
|
| Ribonucleases | 1 | 2013 | 52 | 0.100 |
Why?
|
| Lactose | 2 | 2004 | 54 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 3 | 2005 | 202 | 0.100 |
Why?
|
| Fungi | 1 | 1992 | 69 | 0.100 |
Why?
|
| Phylogeny | 2 | 2011 | 687 | 0.100 |
Why?
|
| Base Pair Mismatch | 3 | 2001 | 22 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2011 | 369 | 0.100 |
Why?
|
| Chromosome Pairing | 1 | 2011 | 7 | 0.090 |
Why?
|
| Drug Design | 1 | 2012 | 153 | 0.090 |
Why?
|
| Chromosome Inversion | 1 | 2011 | 73 | 0.090 |
Why?
|
| Ciprofloxacin | 2 | 2023 | 65 | 0.090 |
Why?
|
| Ecosystem | 1 | 2011 | 77 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 772 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 363 | 0.080 |
Why?
|
| Meiosis | 3 | 2024 | 112 | 0.080 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 2010 | 21 | 0.080 |
Why?
|
| Microbial Viability | 1 | 2010 | 42 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 665 | 0.080 |
Why?
|
| Gene Duplication | 1 | 2011 | 363 | 0.080 |
Why?
|
| Genetic Markers | 1 | 2011 | 605 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2013 | 381 | 0.080 |
Why?
|
| Yeasts | 1 | 2009 | 43 | 0.080 |
Why?
|
| Mutagenicity Tests | 1 | 2008 | 36 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 387 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 767 | 0.070 |
Why?
|
| Endodeoxyribonucleases | 2 | 2024 | 46 | 0.070 |
Why?
|
| Fanconi Anemia Complementation Group G Protein | 1 | 2006 | 2 | 0.070 |
Why?
|
| Peroxidases | 1 | 2006 | 26 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2019 | 2652 | 0.070 |
Why?
|
| Fanconi Anemia | 1 | 2006 | 44 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2011 | 715 | 0.060 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 2 | 2003 | 9 | 0.060 |
Why?
|
| MutL Proteins | 2 | 2003 | 19 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2006 | 291 | 0.060 |
Why?
|
| Gene Deletion | 3 | 2011 | 793 | 0.060 |
Why?
|
| Flap Endonucleases | 1 | 2025 | 4 | 0.060 |
Why?
|
| Templates, Genetic | 1 | 2025 | 97 | 0.060 |
Why?
|
| Chromosome Duplication | 2 | 2019 | 147 | 0.060 |
Why?
|
| Smith-Magenis Syndrome | 2 | 2019 | 105 | 0.060 |
Why?
|
| Kinetics | 2 | 2004 | 1333 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2004 | 192 | 0.060 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2004 | 43 | 0.060 |
Why?
|
| Plasmids | 3 | 2009 | 513 | 0.060 |
Why?
|
| Geologic Sediments | 1 | 2003 | 5 | 0.050 |
Why?
|
| Air Microbiology | 1 | 2003 | 11 | 0.050 |
Why?
|
| Chromosome Disorders | 2 | 2019 | 311 | 0.050 |
Why?
|
| Water Microbiology | 1 | 2003 | 25 | 0.050 |
Why?
|
| Guanosine Tetraphosphate | 1 | 2023 | 6 | 0.050 |
Why?
|
| Digestive System | 1 | 2003 | 63 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2023 | 79 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 91 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 809 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 1694 | 0.050 |
Why?
|
| Mitochondria | 1 | 2006 | 679 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 772 | 0.050 |
Why?
|
| Genotype | 3 | 2015 | 2569 | 0.050 |
Why?
|
| Genes, Fungal | 2 | 2008 | 63 | 0.040 |
Why?
|
| Salmonella | 1 | 2000 | 28 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2000 | 216 | 0.040 |
Why?
|
| Bacteria | 1 | 2004 | 481 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2003 | 654 | 0.040 |
Why?
|
| Abnormalities, Multiple | 2 | 2019 | 960 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2019 | 81 | 0.040 |
Why?
|
| Phleomycins | 1 | 2018 | 6 | 0.040 |
Why?
|
| Exonucleases | 1 | 2018 | 23 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2013 | 808 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2019 | 88 | 0.040 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 88 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 174 | 0.040 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1998 | 121 | 0.030 |
Why?
|
| Rad51 Recombinase | 1 | 2016 | 29 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2013 | 528 | 0.030 |
Why?
|
| Bacteriophage P1 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Ethylnitrosourea | 1 | 2015 | 7 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 135 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 306 | 0.030 |
Why?
|
| Genes | 1 | 1976 | 447 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 38 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 1587 | 0.030 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2013 | 14 | 0.030 |
Why?
|
| Cytidine Deaminase | 1 | 2013 | 31 | 0.030 |
Why?
|
| Ku Autoantigen | 1 | 2013 | 21 | 0.030 |
Why?
|
| Synthetic Biology | 1 | 2013 | 13 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 681 | 0.020 |
Why?
|
| Mice | 2 | 2023 | 17744 | 0.020 |
Why?
|
| Fish Proteins | 1 | 2011 | 5 | 0.020 |
Why?
|
| Caribbean Region | 1 | 2011 | 19 | 0.020 |
Why?
|
| Genetic Speciation | 1 | 2011 | 25 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 133 | 0.020 |
Why?
|
| Phylogeography | 1 | 2011 | 17 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 1993 | 358 | 0.020 |
Why?
|
| Recombinases | 1 | 2011 | 22 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2011 | 90 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2011 | 167 | 0.020 |
Why?
|
| Head | 1 | 2011 | 104 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 161 | 0.020 |
Why?
|
| Time Factors | 1 | 2000 | 6324 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 187 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 619 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2010 | 63 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 182 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 88 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 1633 | 0.020 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2011 | 310 | 0.020 |
Why?
|
| Eukaryotic Cells | 1 | 1988 | 32 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2008 | 95 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2008 | 283 | 0.020 |
Why?
|
| Proteins | 1 | 2013 | 1039 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2012 | 442 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2008 | 153 | 0.020 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2007 | 27 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2011 | 801 | 0.020 |
Why?
|
| Peroxiredoxin III | 1 | 2006 | 2 | 0.020 |
Why?
|
| Peroxiredoxins | 1 | 2006 | 9 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2006 | 65 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 1109 | 0.020 |
Why?
|
| Mitomycin | 1 | 2006 | 49 | 0.020 |
Why?
|
| Calpain | 1 | 2006 | 40 | 0.020 |
Why?
|
| Peroxidase | 1 | 2006 | 69 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 1338 | 0.020 |
Why?
|
| COS Cells | 1 | 2006 | 275 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 199 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 112 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2008 | 475 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 875 | 0.020 |
Why?
|
| DNA, Catenated | 1 | 2005 | 3 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 461 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2006 | 142 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 128 | 0.020 |
Why?
|
| DNA, Superhelical | 1 | 2005 | 20 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 442 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2006 | 408 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 307 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2524 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2005 | 290 | 0.010 |
Why?
|
| F Factor | 1 | 2004 | 3 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 4843 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2006 | 887 | 0.010 |
Why?
|
| Sildenafil Citrate | 1 | 2001 | 55 | 0.010 |
Why?
|
| Sulfones | 1 | 2001 | 74 | 0.010 |
Why?
|
| Purines | 1 | 2001 | 116 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2001 | 204 | 0.010 |
Why?
|
| Interphase | 1 | 1999 | 48 | 0.010 |
Why?
|
| Piperazines | 1 | 2001 | 242 | 0.010 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 1998 | 198 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2001 | 879 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 12597 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1976 | 184 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 14142 | 0.010 |
Why?
|
| Child | 1 | 2011 | 24606 | 0.010 |
Why?
|
| Male | 1 | 2011 | 61626 | 0.000 |
Why?
|
| Female | 1 | 2011 | 66887 | 0.000 |
Why?
|